Sanofi (SNYNF) Non-Current Receivables (2018 - 2025)
Historic Non-Current Receivables for Sanofi (SNYNF) over the last 8 years, with Q4 2025 value amounting to $640.3 million.
- Sanofi's Non-Current Receivables rose 699.66% to $640.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $640.3 million, marking a year-over-year increase of 699.66%. This contributed to the annual value of $621.6 million for FY2025, which is 254.85% up from last year.
- Per Sanofi's latest filing, its Non-Current Receivables stood at $640.3 million for Q4 2025, which was up 699.66% from $1.9 billion recorded in Q3 2025.
- Sanofi's 5-year Non-Current Receivables high stood at $1.9 billion for Q3 2025, and its period low was $138.9 million during Q2 2024.
- Moreover, its 5-year median value for Non-Current Receivables was $254.1 million (2022), whereas its average is $569.6 million.
- Its Non-Current Receivables has fluctuated over the past 5 years, first plummeted by 4684.41% in 2024, then skyrocketed by 34082.69% in 2025.
- Quarter analysis of 5 years shows Sanofi's Non-Current Receivables stood at $200.2 million in 2021, then grew by 23.33% to $246.9 million in 2022, then decreased by 18.07% to $202.3 million in 2023, then surged by 195.84% to $598.4 million in 2024, then rose by 7.0% to $640.3 million in 2025.
- Its Non-Current Receivables was $640.3 million in Q4 2025, compared to $1.9 billion in Q3 2025 and $612.4 million in Q2 2025.